Hepion Pharmaceuticals, Inc. (HEPA)
USD 0.56
(0.61%)
USD 0.56
(0.61%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 67.13 Thousand | 77.46 Thousand | 86.07 Thousand | 34.51 Thousand | 26.73 Thousand | 18.78 Thousand |
| Gross Profit | -67.13 Thousand | -77.46 Thousand | -86.07 Thousand | -34.51 Thousand | -26.73 Thousand | -18.78 Thousand |
| Operating Expenses | 48.44 Million | 43.61 Million | 30.4 Million | 20.14 Million | 7.77 Million | 14.59 Million |
| Selling, General and Administrative Expenses | 9.61 Million | 10.34 Million | 10 Million | 8.14 Million | 4.58 Million | 7 Million |
| Research and Development Expenses | 35.63 Million | 33.26 Million | 20.39 Million | 11.99 Million | 3.18 Million | 7.59 Million |
| Other Expenses | 3.19 Million | - | - | - | -179.65 Thousand | -108.94 Thousand |
| Cost and Expenses | 48.44 Million | 43.61 Million | 30.4 Million | 20.14 Million | 7.77 Million | 14.59 Million |
| Operating Income | -48.44 Million | -45.48 Million | -30.4 Million | -20.14 Million | -7.77 Million | -14.59 Million |
| Interest Expense | 9465.00 | 10.16 Thousand | 8859.00 | 31.22 Thousand | 554.99 Thousand | 339.15 Thousand |
| Income Tax Expense | 409.02 Thousand | -2.88 Million | 8859.00 | 30.58 Thousand | -908.68 Thousand | -536 Thousand |
| Earnings before Tax | -49.33 Million | -45.08 Million | -32.72 Million | -20.32 Million | -7.94 Million | -9.98 Million |
| Net Income | -48.92 Million | -42.2 Million | -32.72 Million | -20.35 Million | -7.03 Million | -9.44 Million |
| Earnings Per Share Basic | -12.32 | -11.07 | -9.31 | -42.06 | -68.88 | -1027.88 |
| Earnings Per Share Diluted | -12.32 | -11.07 | -9.31 | -42.06 | -68.88 | -1027.88 |
| Weighted Average Shares Outstanding | 3.97 Million | 3.81 Million | 3.51 Million | 483.89 Thousand | 102.16 Thousand | 9193.00 |
| Weighted Average Shares Outstanding (Diluted) | 3.97 Million | 3.81 Million | 3.51 Million | 483.89 Thousand | 102.16 Thousand | 9193.00 |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -49.25 Million | -43.54 Million | -30.31 Million | -20.11 Million | -7.74 Million | -14.57 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | 109.73 Thousand | - | - |
| Cost of Revenue | - | 30.75 Thousand | 67.13 Thousand | 12.26 Thousand | 18.5 Thousand | 18.32 Thousand |
| Gross Profit | - | -30.75 Thousand | -67.13 Thousand | 97.46 Thousand | -18.5 Thousand | -18.32 Thousand |
| Operating Expenses | 8.5 Million | 5.15 Million | 45.19 Million | 7.21 Million | 10.66 Million | 14.16 Million |
| Selling, General and Administrative Expenses | 1.36 Million | 2.61 Million | - | 1.77 Million | 2.14 Million | 2.28 Million |
| Research and Development Expenses | 7.13 Million | 2.53 Million | - | 5.44 Million | 8.51 Million | 11.88 Million |
| Other Expenses | - | - | 3.19 Million | 3.19 Million | - | - |
| Cost and Expenses | 8.5 Million | 5.18 Million | 45.25 Million | 7.21 Million | 10.66 Million | 14.16 Million |
| Operating Income | -8.5 Million | -5.18 Million | -45.25 Million | -10.4 Million | -10.66 Million | -14.16 Million |
| Interest Expense | 49.53 Thousand | 4349.00 | -9465.00 | -14.13 Thousand | - | 2351.00 |
| Income Tax Expense | - | -2.96 Million | -409.02 Thousand | -409.02 Thousand | -137.61 Thousand | 2351.00 |
| Earnings before Tax | -3.92 Million | -5.82 Million | -49.33 Million | -11.46 Million | -10.52 Million | -14.07 Million |
| Net Income | -3.92 Million | -2.85 Million | -48.92 Million | -11.05 Million | -10.52 Million | -14.07 Million |
| Earnings Per Share Basic | -0.68 | -0.56 | - | -2.42 | -2.74 | -3.68 |
| Earnings Per Share Diluted | -0.68 | -0.56 | - | -2.42 | -2.74 | -3.68 |
| Weighted Average Shares Outstanding | 5.79 Million | 5.07 Million | 3.97 Million | 4.56 Million | 3.83 Million | 3.82 Million |
| Weighted Average Shares Outstanding (Diluted) | 5.79 Million | 5.07 Million | 3.97 Million | 4.56 Million | 3.83 Million | 3.82 Million |
| Gross Margin | - | - | - | 0.89 | - | - |
| EBIT Margin | - | - | - | -64.03 | - | - |
| Profit Margin | - | - | - | -100.79 | - | - |
| EBITDA | -8.5 Million | -5.15 Million | - | -7.02 Million | -10.78 Million | -14.14 Million |
| Earnings Before Tax Margin | - | - | - | -94.86 | - | - |
EPL
AAC
NSSC
NLY
8370
CNXC